FDA

Regulus Therapeutics Inc Reports, FDA has put Clinical Hold on Investigational New Drug RG-101

Carlsbad, California based Regulus Therapeutics Inc. is a biopharmaceutical company that is involved in discovery and development of pioneering medicines which target microRNAs. The company announced it has received a verbal notice from the U. S. Food and Drug Administration (FDA) which says its Investigational New Drug RG-101, which aims at treating chronic hepatitis C virus infection, has been placed on clinical hold.

Sarepta Shares Rise as FDA Requests for Additional Information on Eteplirsen, a Duchenne Treatment

On Monday, Sarepta Therapeutics Inc's shares spiked during late trading hours with news that the U.S. Food and Drug Administration has asked for more information from the drug maker regarding its experimental treatment for muscular dystrophy.

Sarepta's shares climbed a sharp thirty one percent during the afterhours trading to $21.05.

FDA to Revise Rules for Food Safety

FDA to Revise Rules for Food SafetyOn Friday, the Food and Drug Administration FDA decided to rewrite the rules for food safety as planned last year, when the farmers protested that the rules set by the FDA may result in hurting the business.

Researchers number puffs taken by ‘vapers’

Researchers number puffs taken by ‘vapers’One group of analysts evalu

FDA recalls from US shelves

FDA recalls from US shelvesIndia's pharmaceutical misfortunes proceed, as the US Food and Drug Administration (FDA) reported this week that it was reviewing 200 vials of items created by Sun Pharmaceuticals Industries Ltd.

The news was advertised by means of an implementation report posted on the FDA's official site, in which it states that 200 vials of a chemotherapy drug known as gemcitabine are, no doubt pulled from US shelves quickly.

FDA approves Cubist Sivextro to treat skin infections

FDA approves Cubist Sivextro to treat skin infectionsSivextro, an antibacterial medication made to treat skin diseases, was affirmed for utilization on Friday, June 20.

Even with genuine diseases, for example, MRSA and strains of Streptococcus, this pill, otherwise called tedizolid phosphate, and others of its kind are an earnest need. Numerous past pills are progressively getting futile because of antimicrobial safety.

Pages